Published Erratum
doi: 10.1148/radiol.2021219014.
Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness
- PMID: 34543148
- PMCID: PMC8474968
- DOI: 10.1148/radiol.2021219014
Item in Clipboard
Published Erratum
Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness
Radiology.
2021 Oct.
No abstract available
Erratum for
-
Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.Radiology. 2021 Sep;300(3):594-604. doi: 10.1148/radiol.2021204321. Epub 2021 Jul 13. Radiology. 2021. PMID: 34254851 Free PMC article.
Similar articles
-
Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.Eur Urol. 2019 Jun;75(6):910-917. doi: 10.1016/j.eururo.2018.10.055. Epub 2018 Nov 10. Eur Urol. 2019. PMID: 30425010
-
The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer.BMC Cancer. 2017 Aug 8;17(1):529. doi: 10.1186/s12885-017-3522-z. BMC Cancer. 2017. PMID: 28789623 Free PMC article.
-
Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance.Cancer. 2018 Feb 1;124(3):507-513. doi: 10.1002/cncr.31141. Epub 2017 Dec 12. Cancer. 2018. PMID: 29231973 Free PMC article.
-
Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.Future Oncol. 2012 Jan;8(1):37-54. doi: 10.2217/fon.11.131. Future Oncol. 2012. PMID: 22149034 Review.
-
The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer.Urol Oncol. 2017 Feb;35(2):51-58. doi: 10.1016/j.urolonc.2016.03.021. Epub 2016 Apr 28. Urol Oncol. 2017. PMID: 27133953 Free PMC article. Review.
Cited by
-
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling.J Natl Cancer Inst. 2025 Apr 1;117(4):685-691. doi: 10.1093/jnci/djae296. J Natl Cancer Inst. 2025. PMID: 39565901
-
A Personalized, Risk-Based Approach to Active Surveillance for Prostate Cancer with Takeaways from Broader Oncology Practices: A Mixed Methods Review.J Pers Med. 2025 Feb 25;15(3):84. doi: 10.3390/jpm15030084. J Pers Med. 2025. PMID: 40137400 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
